Lower Prevalence of the OCT2 Ser270 Allele in Patients with Essential Hypertension
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 28 (7) , 645-653
- https://doi.org/10.1080/10641960600946411
Abstract
Impairment of the renal dopaminergic pathway has been shown to result in essential hypertension. The Organic Cation Transporter 2, OCT2 (SLC22A2), has been implicated in renal dopamine handling as well as in the inactivation of circulating catecholamines and is supposed to be involved in blood pressure regulation. This study investigated the association of the OCT2 Ala270Ser polymorphism with essential hypertension and its impact on blood pressure status in 607 Caucasian patients who underwent left heart catheterization. Clinical characteristics and diagnosis were recorded and blood pressure was determined by intravascular measurement. A comparison of genotypes revealed that patients with the Ser270 allele were less frequently affected by the clinical diagnosis of hypertension than homozygous carriers of the wild type allele Ala270 (Kruskal Wallis test, p = 0.028). This relation was even more pronounced in the subgroup of patients without diabetes mellitus (Kruskal Wallis test, p = 0.013). In summary, the first data on OCT2 are presented in the context of a candidate gene analysis. The Ala270Ser polymorphism was significantly associated with essential hypertension in the present sample. This study further suggests a function of OCT2 in blood pressure homeostasis and points to the potential role of the transporter in the development of essential hypertension.Keywords
This publication has 23 references indexed in Scilit:
- Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further researchPharmacogenomics, 2003
- Genome-wide mapping of human loci for essential hypertensionThe Lancet, 2003
- Renin–Angiotensin–Aldosterone System Loci and Multilocus Interactions in Young‐Onset Essential HypertensionClinical and Experimental Hypertension, 2003
- Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the YoungNew England Journal of Medicine, 2001
- The organic cation transporter OCT2 mediates the uptake of β‐adrenoceptor antagonists across the apical membrane of renal LLC‐PK1 cell monolayersBritish Journal of Pharmacology, 2000
- An Extreme-Sib-Pair Genome Scan for Genes Regulating Blood PressureAmerican Journal of Human Genetics, 1999
- Primary Structure and Functional Expression of the Apical Organic Cation Transporter from Kidney Epithelial LLC-PK1CellsPublished by Elsevier ,1997
- A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.Journal of Clinical Investigation, 1997
- cDNA Cloning and Functional Expression of a Novel Rat Kidney Organic Cation Transporter, OCT2Biochemical and Biophysical Research Communications, 1996
- Dopamine action and metabolism in the kidneyCurrent Opinion in Nephrology and Hypertension, 1994